文献速递心血管MR

超小假顺磁性氧化铁纳米颗粒作为新型血池T1磁共振对比剂用于3 T犬全心脏冠状动脉血管造影:与钆特酸葡胺的比较

Extremely Small Pseudoparamagnetic Iron Oxide Nanoparticle as a Novel Blood Pool T1 Magnetic Resonance Contrast Agent for 3 T Whole-Heart Coronary Angiography in Canines: Comparison With Gadoterate Meglumine.
PubMed 文献 · Invest Radiol · 2017-01-01

在9只杂种犬中,于3 T扫描仪上分别使用钆特酸葡胺(Gd-DOTA)和超小假顺磁性氧化铁纳米颗粒(ESPIO,KEG3)进行全心脏冠状动脉磁共振血管造影,注射对比剂时及注射后15分钟各扫描一次。KEG3在注射时图像质量与Gd-DOTA相当,在15分钟延迟扫描时信噪比、对比噪声比及主观评分均优于Gd-DOTA。

要点

  • 注射对比剂时,KEG3与Gd-DOTA的冠状动脉信噪比和对比噪声比无显著差异。
  • 注射后15分钟延迟扫描,KEG3的冠状动脉信噪比和对比噪声比均高于Gd-DOTA两倍以上。
  • KEG3在延迟扫描的主观图像质量评分显著优于Gd-DOTA。

核心结论

  • 实验性血池对比剂KEG3在3 T全心脏冠状动脉磁共振血管造影中,注射时图像质量与传统的细胞外钆对比剂相当,且在后续延迟扫描中持续保持更优质量。

研究设计与样本

  • 动物实验,9只杂种犬,于3 T扫描仪使用FLASH序列,分别注射Gd-DOTA或ESPIO(KEG3),间隔7天进行两次检查,每次检查于注射对比剂时及注射后15分钟各扫描一次。

关键影像表现/征象

  • 注射对比剂时,KEG3图像中冠状动脉信噪比为98.1 ± 32.5,Gd-DOTA为79.1 ± 38.4,P = 0.3。
  • 注射对比剂时,KEG3图像中血管与脂肪及心肌的对比噪声比为74.2 ± 30.1,Gd-DOTA为61.4 ± 38.5,P = 0.7。
  • 注射后15分钟,KEG3图像中冠状动脉信噪比为95.2 ± 31.3,Gd-DOTA为32.1 ± 8.1,P = 0.008。
  • 注射后15分钟,KEG3图像中血管与脂肪及心肌的对比噪声比为76.1 ± 35.8,Gd-DOTA为17.6 ± 19.2,P = 0.008。

诊断标准与关键数值

  • 主观图像质量采用4分制评分,注射对比剂时KEG3冠状动脉评分为3.9 ± 0.3,Gd-DOTA为3.3 ± 0.8,P = 0.1。
  • 注射后15分钟,KEG3冠状动脉主观评分为3.9 ± 0.2,Gd-DOTA为2.1 ± 0.6,P = 0.007。

临床应用与阅片要点

  • 本实验提示KEG3作为血池对比剂在注射时即可获得与Gd-DOTA相当的冠状动脉图像质量。
  • 本实验提示KEG3在注射后15分钟延迟扫描仍保持较高的冠状动脉信噪比和对比噪声比。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The aim of this study was to evaluate an extremely small pseudoparamagnetic iron oxide nanoparticle (ESPIO), KEG3, as a potential blood pool agent in 3 T coronary magnetic resonance angiography (MRA) in canine models and compare its efficacy to that of a gadolinium-based contrast agent.

MATERIALS AND METHODS: Nine mongrel dogs were subjected to whole-heart coronary MRA in 2 separate sessions at 7-day intervals with a 3 T scanner using the FLASH sequence with either gadoterate meglumine (Gd-DOTA) or the ESPIO (KEG3). Coronary MRA was performed twice at each MR examination: the first scan during the administration of the contrast agent and the subsequent second scan at 15 minutes after contrast injection. Objective measurements of the Gd-DOTA and ESPIO images, including the signal-to-noise ratios (SNRs) for the coronary arteries and cardiac veins, contrast-to-noise ratios (CNRs) between the vessels and fat (CNRfat) and the vessels and the myocardium (CNRmyocardium), and subjective image quality scores on a 4-point scale were evaluated and compared.

RESULTS: The mean SNRs and CNRs of all vascular regions in the ESPIO images were similar to those of the corresponding regions in the Gd-DOTA images in the first scan (98.1 ± 32.5 vs 79.1 ± 38.4 for SNR of coronary arteries, P = 0.3; 74.2 ± 30.1 vs 61.4 ± 38.5 for CNR, P = 0.7) and more than 2 times higher than the latter in the second scan (95.2 ± 31.3 vs 32.1 ± 8.1 for SNR of coronary arteries, P = 0.008; 76.1 ± 35.8 vs 17.6 ± 19.2 for CNR, P 0.008). Similarly, the mean values of the subjective measurements of the ESPIO images were similar to those of the Gd-DOTA images (3.9 ± 0.3 vs 3.3 ± 0.8 for coronary arteries, P = 0.1) in the first scan and significantly better than the latter in the second scan (3.9 ± 0.2 vs 2.1 ± 0.6 for coronary arteries, P = 0.007).

CONCLUSIONS: The experimental blood pool agent KEG3 offers equivalent image quality for whole-heart coronary MRA at 3 T upon contrast administration and persistent better quality in the subsequent scans, compared with a traditional extracellular gadolinium-based contrast agent.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Park EA, Lee W, So YH, et al. Extremely Small Pseudoparamagnetic Iron Oxide Nanoparticle as a Novel Blood Pool T1 Magnetic Resonance Contrast Agent for 3 T Whole-Heart Coronary Angiography in Canines: Comparison With Gadoterate Meglumine. Invest Radiol. 2017. PMID: 27977466. doi:10.1097/RLI.0000000000000321

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。